Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Peter Stockham, Emma Partridge, Sam Alfred, Laura Boyle, Andrew Camilleri, Hannah Green, Daniel Haustead, Melissa Humphries, Chris Kostakis & Jake Mallon. (2023) Characteristics of analytically confirmed gamma-hydroxybutyrate (GHB) positive patients in the emergency department: presentation, poly-drug use, disposition and impact on intensive care resource utilisation. Clinical Toxicology 61:4, pages 241-247.
Read now
Read now
Rebekah Brennan & Marie Claire Van Hout. (2014) Gamma-Hydroxybutyrate (GHB): A Scoping Review of Pharmacology, Toxicology, Motives for Use, and User Groups. Journal of Psychoactive Drugs 46:3, pages 243-251.
Read now
Read now
Leo J Schep, Kai Knudsen, Robin J Slaughter, J Allister Vale & Bruno Mégarbane. (2012) The clinical toxicology of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol. Clinical Toxicology 50:6, pages 458-470.
Read now
Read now
Christian Grov, Brian C. Kelly & Jeffrey T. Parsons. (2009) Polydrug Use Among Club-Going Young Adults Recruited Through Time-Space Sampling. Substance Use & Misuse 44:6, pages 848-864.
Read now
Read now
Shirley J. Semple, Steffanie A. Strathdee, Jim Zians & Thomas L. Patterson. (2009) Sexual Risk Behavior Associated with Co-administration of Methamphetamine and Other Drugs in a Sample of HIV-Positive Men Who Have Sex with Men. American Journal on Addictions 18:1, pages 65-72.
Read now
Read now
Fridtjof Heyerdahl, Maria Bjornas, Knut Erik Hovda, Karina Skog, Anders Opdahl, Cecilie Wium, Oivind Ekeberg & Dag Jacobsen. (2008) Acute poisonings treated in hospitals in Oslo: A one-year prospective study (II): Clinical outcome. Clinical Toxicology 46:1, pages 42-49.
Read now
Read now
Kai Knudsen, Joachim Greter & Mario Verdicchio. (2008) High mortality rates among GHB abusers in Western Sweden. Clinical Toxicology 46:3, pages 187-192.
Read now
Read now
K.E. Hovda, M.A. Bjornaas, K. Skog, A. Opdahl, P. Drottning, O. Ekeberg & D. Jacobsen. (2008) Acute poisonings treated in hospitals in Oslo: A one-year prospective study (I): Pattern of poisoning. Clinical Toxicology 46:1, pages 35-41.
Read now
Read now
Diederik K. Van Sassenbroeck, Nikolaas De Neve, Peter De Paepe, Frans M. Belpaire, Alain G. Verstraete, Paul A. Calle & Walter A. Buylaert. (2007) Abrupt awakening phenomenon associated with gamma-hydroxybutyrate use: A case series. Clinical Toxicology 45:5, pages 533-538.
Read now
Read now
Deborah L. Zvosec, Stephen W. Smith, Regina Litonjua & Richard E.J. Westfal. (2007) Physostigmine for gamma-hydroxybutyrate coma: Inefficacy, adverse events, and review. Clinical Toxicology 45:3, pages 261-265.
Read now
Read now
Uttam Garg, David Scott$suffix/text()$suffix/text(), Mike Kiscoan, Jeff Knoblauch, C. Clinton Frazee$suffix/text()$suffix/text() & Gary Wasserman. (2007) Letter to the Editor: “Use of urine organic acids method for the analysis of gamma-hydroxybutric acid (GHB): Importance of urease in eliminating urea interference”. Clinical Toxicology 45:2, pages 194-196.
Read now
Read now
M. A. Bjornaas, K. E. Hovda, H. Mikalsen, E. Andrew, N. Rudberg, O. Ekeberg & D. Jacobsen. (2006) Clinical vs. Laboratory Identification of Drugs of Abuse in Patients Admitted for Acute Poisoning. Clinical Toxicology 44:2, pages 127-134.
Read now
Read now
Louisa Degenhardt, Jan Copeland & Paul Dillon. (2005) Recent Trends in the Use of “Club Drugs”: An Australian Review. Substance Use & Misuse 40:9-10, pages 1241-1256.
Read now
Read now
RobertS. Gable. (2004) Acute Toxic Effects of Club Drugs. Journal of Psychoactive Drugs 36:3, pages 303-313.
Read now
Read now
Articles from other publishers (56)
Laurene Dufayet, Sophie Bargel, Anastasia Bonnet, Arezki Khaled Boukerma, Cécile Chevallier, Marion Evrard, Sophie Guillotin, Elodie Loeuillet, Camille Paradis, Alix Marie Pouget, Julien Reynoard & Jules-Antoine Vaucel. (2023) Gamma-hydroxybutyrate (GHB), 1,4-butanediol (1,4BD), and gamma-butyrolactone (GBL) intoxication: A state-of-the-art review. Regulatory Toxicology and Pharmacology, pages 105435.
Crossref
Crossref
Laurène Dufayet, Sophie Bargel, Anastasia Bonnet, Arezki Khaled Boukerma, Cécile Chevallier, Marion Evrard, Sophie Guillotin, Elodie Loeuillet, Camille Paradis, Alix Marie Pouget, Julien Reynoard & Jules-Antoine Vaucel. (2023) Acide γ-Hydroxybutyrique (GHB), γ-butyrolactone (GBL) et 1,4-butanediol (1,4-BD) : revue de la littérature des aspects pharmacologiques, cliniques, analytiques et médico-légaux. Toxicologie Analytique et Clinique 35:1, pages 1-22.
Crossref
Crossref
Madelaine Abid, Jana Kietzerow, Stefanie Iwersen‐Bergmann, Tino Schnitgerhans & Hilke Andresen‐Streichert. (2021) Characteristics and dose‐effect relationship of clinical gamma‐hydroxybutyrate intoxication: A case series. Journal of Forensic Sciences 67:1, pages 416-427.
Crossref
Crossref
Cassandra R. Doyno & C. Michael White. (2021) Sedative‐Hypnotic Agents That Impact Gamma‐Aminobutyric Acid Receptors: Focus on Flunitrazepam, Gamma‐Hydroxybutyric Acid, Phenibut, and Selank. The Journal of Clinical Pharmacology 61:S2.
Crossref
Crossref
Thomas A Smits, Femke MJ Gresnigt, Milly E Attema-de Jonge & Eric JF Franssen. (2021) Can emergency department clinicians diagnose gamma-hydroxybutyrate (GHB) intoxication based on clinical observations alone?. Emergency Medicine Journal 38:7, pages 520-523.
Crossref
Crossref
Lidwien P.F.M. van Helmond & Femke M.J. Gresnigt. (2019) Safety of withholding intubation in gamma-hydroxybutyrate and gamma-butyrolactone-intoxicated coma patients in the emergency department. European Journal of Emergency Medicine, pages 1.
Crossref
Crossref
Miguel Galicia, Paul I. Dargan, Alison M. Dines, Christopher Yates, Fridtjof Heyerdahl, Knut Erik Hovda, Isabella Giraudon, David M. Wood, Òscar Miró, Jacek Sein Anand, Jeffrey Bonnici, Blazena Caganova, Florian Eyer, Gesche Jürgens, Piotr Maciej Kabata, Evangelia Liakoni, Matthias E Liechti, Bruno Mégarbane, Adrian Moughty, Niall O'Connor, Raido Paasma, Per Sverre Persett, Kristiina Põld, Julia Radenkova–Saeva, Irene Scholz, Odd Martin Vallersnes, W Stephen Waring & Sergej Zacharov. (2019) Clinical relevance of ethanol coingestion in patients with GHB/GBL intoxication. Toxicology Letters 314, pages 37-42.
Crossref
Crossref
Jonathan Henssler & Felix Bermpohl. 2018. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen
631
642
.
R. Bellmann & M. Joannidis. (2017) Vergiftungen mit psychotropen SubstanzenIntoxication with psychotropic drugs. Medizinische Klinik - Intensivmedizin und Notfallmedizin 112:6, pages 557-575.
Crossref
Crossref
Sarah Wurts Black, Akihiro Yamanaka & Thomas S. Kilduff. (2017) Challenges in the development of therapeutics for narcolepsy. Progress in Neurobiology 152, pages 89-113.
Crossref
Crossref
Alan D. Brailsford, Christiaan Bartlett, Andrew T. Kicman & David A. Cowan. (2017) Increases in Serum Growth Hormone Concentrations Associated with GHB Administration. Journal of Analytical Toxicology 41:1, pages 54-59.
Crossref
Crossref
David M. Wood. 2017. Critical Care Toxicology. Critical Care Toxicology
1555
1586
.
Evangelia Liakoni, Fabio Walther, Christian H. Nickel & Matthias E. Liechti. (2016) Presentations to an urban emergency department in Switzerland due to acute γ-hydroxybutyrate toxicity. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 24:1.
Crossref
Crossref
F. Erbguth. (2015) Mode- und DesignerdrogenParty and designer drugs. Medizinische Klinik - Intensivmedizin und Notfallmedizin 111:7, pages 630-637.
Crossref
Crossref
Jonathan Henssler & Felix Bermpohl. 2017. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen
1
16
.
David M. Wood. 2016. Critical Care Toxicology. Critical Care Toxicology
1
32
.
John M. Corkery, Barbara Loi, Hugh Claridge, Christine Goodair, Ornella Corazza, Simon Elliott & Fabrizio Schifano. (2015) Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use. Neuroscience & Biobehavioral Reviews 53, pages 52-78.
Crossref
Crossref
Luc Heytens, Hugo Neels, Niels Van Regenmortel, Wim van den Brink, Manu Henckes, Sofie Schouwers, Greet Dockx & Cleo L Crunelle. (2014) Near-fatal persistent anion- and osmolal-gap acidosis due to massive gamma-butyrolactone/ethanol intoxication. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 52:2, pages 283-287.
Crossref
Crossref
Jon Streltzer. 2015. Handbook of Consultation-Liaison Psychiatry. Handbook of Consultation-Liaison Psychiatry
279
290
.
Margareta Warrén Stomberg, Kai Knudsen, Henrik Stomberg & Ingela Skärsäter. (2014) Symptoms and signs in interpreting Gamma-hydroxybutyrate (GHB) intoxication - an explorative study. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 22:1.
Crossref
Crossref
Sushabhan Sadhukhan, Guo-Fang Zhang & Gregory P. Tochtrop. (2014) Modular Isotopomer Synthesis of γ-Hydroxybutyric Acid for a Quantitative Analysis of Metabolic Fates. ACS Chemical Biology 9:8, pages 1706-1711.
Crossref
Crossref
Raya Brandenburg, Sylvia Brinkman, Nicolette F. de Keizer, Jan Meulenbelt & Dylan W. de Lange. (2014) In-Hospital Mortality and Long-Term Survival of Patients With Acute Intoxication Admitted to the ICU*. Critical Care Medicine 42:6, pages 1471-1479.
Crossref
Crossref
Janice E. Sullivan & Mark J. McDonald. 2014. Pediatric Critical Care Medicine. Pediatric Critical Care Medicine
695
727
.
Roland Freudenmann. (2013) Was ist Liquid Ecstasy?. InFo Neurologie & Psychiatrie 15:11, pages 38-43.
Crossref
Crossref
Christian Berchtold, Stefan Schmid, Lukas Meier & Renato Zenobi. (2013) In situ detection of γ-hydroxybutyrate and γ-butyrolactone in drinks by secondary electrospray ionization. Anal. Methods 5:4, pages 844-850.
Crossref
Crossref
F. Erbguth. 2013. Bewusstseinsstörungen und Enzephalopathien. Bewusstseinsstörungen und Enzephalopathien
419
428
.
Martin J. Dutch & Kristy B. Austin. (2012) Hospital in the Field: Prehospital Management of GHB Intoxication by Medical Assistance Teams. Prehospital and Disaster Medicine 27:5, pages 463-467.
Crossref
Crossref
Jan G.C. van Amsterdam, Margriet van Laar, Tibor M. Brunt & Wim van den Brink. (2012) Risk assessment of gamma-hydroxybutyric acid (GHB) in the Netherlands. Regulatory Toxicology and Pharmacology 63:1, pages 55-63.
Crossref
Crossref
Donald G. Barceloux. 2012. Medical Toxicology of Drug Abuse. Medical Toxicology of Drug Abuse
89
109
.
A. D. Brailsford, D. A. Cowan & A. T. Kicman. (2012) Pharmacokinetic Properties of -Hydroxybutyrate (GHB) in Whole Blood, Serum, and Urine. Journal of Analytical Toxicology 36:2, pages 88-95.
Crossref
Crossref
David M. Wood, Alan D. Brailsford & Paul I. Dargan. (2011) Acute toxicity and withdrawal syndromes related to gamma-hydroxybutyrate (GHB) and its analogues gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD). Drug Testing and Analysis 3:7-8, pages 417-425.
Crossref
Crossref
Deborah Zvosec & Stephen Smith. (2011) Response to “A Web-Based Study of Gamma Hydroxybutyrate (GHB): Patterns, Experiences, and Functions of Use”. The American Journal on Addictions 20:3, pages 300-301.
Crossref
Crossref
François Marclay, Christophe Saudan, Julie Vienne, Mehdi Tafti & Martial Saugy. (2011) Source inference of exogenous gamma-hydroxybutyric acid (GHB) administered to humans by means of carbon isotopic ratio analysis: novel perspectives regarding forensic investigation and intelligence issues. Analytical and Bioanalytical Chemistry 400:4, pages 1105-1112.
Crossref
Crossref
Pamela C. Brown, Jacqueline Alfonso & Michael E. Dunn. (2011) Gamma Hydroxybutyrate Use: Exploring the Influence of Outcome Expectancies Through Memory Modeling. The American Journal on Addictions, pages no-no.
Crossref
Crossref
Leon Gussow & Andrea Carlson. 2010. Rosen's Emergency Medicine – Concepts and Clinical Practice. Rosen's Emergency Medicine – Concepts and Clinical Practice
2071
2079
.
Barbara Hefele, Nora Naumann, Regina Trollmann, Katalin Dittrich & Wolfgang Rascher. (2009) Fast-in, fast-out. The Lancet 373:9672, pages 1398.
Crossref
Crossref
Jeffrey T. Parsons, Christian Grov & Brian C. Kelly. (2009) Club Drug Use and Dependence among Young Adults Recruited through Time-Space Sampling. Public Health Reports 124:2, pages 246-254.
Crossref
Crossref
Ò. Miró, M. Galicia & S. Nogué. (2009) Cocaína: una causa de patología que no cesa. Revista Clínica Española 209:2, pages 104-105.
Crossref
Crossref
Joshua T. Kantrowitz, Leslie Citrome & Daniel C. Javitt. (2009) A review of tolerability and abuse liability of γ-hydroxybutyric acid for insomnia in patients with schizophrenia. Clinical Therapeutics 31, pages 1360-1373.
Crossref
Crossref
Venita L Munir, Jennie E Hutton, Jason P Harney, Penny Buykx, Tracey J Weiland & Andrew W Dent. (2008) Gamma-hydroxybutyrate: A 30 month emergency department review. Emergency Medicine Australasia 20:6, pages 521-530.
Crossref
Crossref
Emma West, Peter Cameron, Gerard O'Reilly, Olaf H Drummer & Adam Bystrzycki. (2008) Accuracy of current clinical diagnosis in recreational drug-related attendance to the emergency department. Emergency Medicine Australasia 20:4, pages 333-338.
Crossref
Crossref
Louisa Degenhardt & Matthew Dunn. (2008) The epidemiology of GHB and ketamine use in an Australian household survey. International Journal of Drug Policy 19:4, pages 311-316.
Crossref
Crossref
Jennifer L. LeTourneau, Daniel S. Hagg & Stephen M. Smith. (2008) Baclofen and Gamma-Hydroxybutyrate Withdrawal. Neurocritical Care 8:3, pages 430-433.
Crossref
Crossref
Harry R. Sumnall, Kerry Woolfall, Sara Edwards, Jon C. Cole & Caryl M. Beynon. (2008) Use, function, and subjective experiences of gamma-hydroxybutyrate (GHB). Drug and Alcohol Dependence 92:1-3, pages 286-290.
Crossref
Crossref
Sergio Abanades, Magi Farré, Diego Barral, Marta Torrens, Neus Closas, Klaus Langohr, Antoni Pastor & Rafael de la Torre. (2007) Relative Abuse Liability of γ-Hydroxybutyric Acid, Flunitrazepam, and Ethanol in Club Drug Users. Journal of Clinical Psychopharmacology 27:6, pages 625-638.
Crossref
Crossref
Jim McCambridge, Adam Winstock, Neil Hunt & Luke Mitcheson. (2007) 5-Year Trends in Use of Hallucinogens and Other Adjunct Drugs among UK Dance Drug Users. European Addiction Research 13:1, pages 57-64.
Crossref
Crossref
LAWRENCE S. QUANG. 2007. Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose. Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose
803
823
.
Stuart T. Leonard, Lisa R. Gerak, Olga Gurkovskaya, Joseph M. Moerschbaecher & Peter J. Winsauer. (2006) Effects of γ-hydroxybutyric acid and flunitrazepam on ethanol intake in male rats. Pharmacology Biochemistry and Behavior 85:4, pages 780-786.
Crossref
Crossref
Eduard Sanjurjo, Elisabet Montori, Santiago Nogué, Miquel Sánchez & Pere Munné. (2006) Urgencias por cocaína: un problema emergente. Medicina Clínica 126:16, pages 616-619.
Crossref
Crossref
Matthias E. Liechti, Isabelle Kunz, Peter Greminger, Rudolf Speich & Hugo Kupferschmidt. (2006) Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use. Drug and Alcohol Dependence 81:3, pages 323-326.
Crossref
Crossref
O. Carter SneadIIIIII & K. Michael Gibson. (2005) γ-Hydroxybutyric Acid. New England Journal of Medicine 352:26, pages 2721-2732.
Crossref
Crossref
Deborah L. Zvosec & Stephen W. Smith. (2005) Agitation is common in γ-hydroxybutyrate toxicity. The American Journal of Emergency Medicine 23:3, pages 316-320.
Crossref
Crossref
Santiago Nogué, Eduard Sanjurjo, Georgina Espigol & Oscar Miró. (2005) Club drugs: nuevos retos para los que trabajan en urgencias. Medicina Clínica 124:6, pages 239.
Crossref
Crossref
Sergio Abanades, Ana M. Peiró & Magí Farré. (2004) Club drugs: los viejos fármacos son las nuevas drogas de la fiesta. Medicina Clínica 123:8, pages 305-311.
Crossref
Crossref
J. Rodgers, C. H. Ashton, E. Gilvarry & A. H. Young. (2018) Liquid ecstasy: a new kid on the dance floor. British Journal of Psychiatry 184:2, pages 104-106.
Crossref
Crossref
Joan Carles Trullàs, Santiago Nogué, Òscar Miró & Pere Munné. (2003) Uso criminal de psicofármacos. A propósito de un brote de 4 casos. Medicina Clínica 121:2, pages 79.
Crossref
Crossref